Specialty pharmacy handles high-cost, complex drugs for chronic conditions. While generics offer major cost savings, their use in this space requires careful patient monitoring, supply chain management, and education - especially with biosimilars now entering the market.
Biosimilars are highly tested, FDA-approved versions of complex biologic drugs. They work the same as the original but cost less. Learn how they differ from generics and why they’re safe for patients.